- Home
- INO vs CVGI Comparison
INO vs CVGI Comparison
Compare INO & CVGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INO | CVGI |
|---|---|---|
| Founded | 1979 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 121.8M |
| IPO Year | 1999 | 2004 |
Fundamental Metrics
Financial Performance| Metric | INO | CVGI |
|---|---|---|
| Price | $1.15 | $4.35 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 498.9K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.18 | ★ 316.18 |
| EPS | N/A | ★ 0.04 |
| Revenue | $42,220,086.00 | ★ $755,231,000.00 |
| Revenue This Year | $20,156.19 | $4.84 |
| Revenue Next Year | $421.95 | $5.36 |
| P/E Ratio | ★ N/A | $103.38 |
| Revenue Growth | ★ 19.37 | 14.06 |
| 52 Week Low | $1.03 | $0.87 |
| 52 Week High | $2.86 | $4.40 |
Technical Indicators
Market Signals| Indicator | INO | CVGI |
|---|---|---|
| Relative Strength Index (RSI) | 36.14 | 66.23 |
| Support Level | $1.03 | $1.51 |
| Resistance Level | $1.56 | $4.40 |
| Average True Range (ATR) | 0.08 | 0.38 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 15.33 | 91.09 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About CVGI Commercial Vehicle Group Inc.
Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.